My bet is that Lenire has a big competitive advantage. It now has a lot of data from patients, which allows them to improve and upgrade the device; this has happened in many industries.
I am still a big believer in Susan Shore, we supported her a lot with the STAT Madness and I will still support her, and I want to believe she is not launching the device until it perfectly works.
But I would also like to thank Lenire for launching the device, they have now a lot of feedback from patients and they can start an internal process to improve and upgrade their treatment in the following years.
If they both are reading this post, please don't stop trying to make our lives better!